JPWO2022114165A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022114165A5 JPWO2022114165A5 JP2022500682A JP2022500682A JPWO2022114165A5 JP WO2022114165 A5 JPWO2022114165 A5 JP WO2022114165A5 JP 2022500682 A JP2022500682 A JP 2022500682A JP 2022500682 A JP2022500682 A JP 2022500682A JP WO2022114165 A5 JPWO2022114165 A5 JP WO2022114165A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- set forth
- sequence set
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022067622A JP7802601B2 (ja) | 2020-11-30 | 2022-04-15 | 線維化の進行抑制剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2020/044406 WO2022113316A1 (ja) | 2020-11-30 | 2020-11-30 | 線維化の進行抑制剤 |
| PCT/JP2021/043543 WO2022114165A1 (ja) | 2020-11-30 | 2021-11-29 | 線維化の進行抑制剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022067622A Division JP7802601B2 (ja) | 2020-11-30 | 2022-04-15 | 線維化の進行抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022114165A1 JPWO2022114165A1 (https=) | 2022-06-02 |
| JPWO2022114165A5 true JPWO2022114165A5 (https=) | 2022-11-08 |
Family
ID=81754505
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531123A Withdrawn JPWO2022113316A1 (https=) | 2020-11-30 | 2020-11-30 | |
| JP2022500682A Withdrawn JPWO2022114165A1 (https=) | 2020-11-30 | 2021-11-29 | |
| JP2022067622A Active JP7802601B2 (ja) | 2020-11-30 | 2022-04-15 | 線維化の進行抑制剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531123A Withdrawn JPWO2022113316A1 (https=) | 2020-11-30 | 2020-11-30 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022067622A Active JP7802601B2 (ja) | 2020-11-30 | 2022-04-15 | 線維化の進行抑制剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240084020A1 (https=) |
| EP (1) | EP4252771A4 (https=) |
| JP (3) | JPWO2022113316A1 (https=) |
| KR (1) | KR20230114698A (https=) |
| CN (1) | CN116829187A (https=) |
| AU (1) | AU2021385871A1 (https=) |
| CA (1) | CA3199351A1 (https=) |
| CL (1) | CL2023001460A1 (https=) |
| IL (1) | IL303159A (https=) |
| MX (1) | MX2023006164A (https=) |
| TW (1) | TW202237182A (https=) |
| WO (2) | WO2022113316A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954916B1 (ja) | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
| MX2022005654A (es) | 2019-11-20 | 2022-06-22 | Chugai Pharmaceutical Co Ltd | Preparacion que contiene anticuerpo. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954916B1 (ja) * | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
-
2020
- 2020-11-30 WO PCT/JP2020/044406 patent/WO2022113316A1/ja not_active Ceased
- 2020-11-30 JP JP2021531123A patent/JPWO2022113316A1/ja not_active Withdrawn
-
2021
- 2021-11-29 IL IL303159A patent/IL303159A/en unknown
- 2021-11-29 AU AU2021385871A patent/AU2021385871A1/en active Pending
- 2021-11-29 EP EP21898137.1A patent/EP4252771A4/en active Pending
- 2021-11-29 MX MX2023006164A patent/MX2023006164A/es unknown
- 2021-11-29 TW TW110144377A patent/TW202237182A/zh unknown
- 2021-11-29 US US18/038,460 patent/US20240084020A1/en active Pending
- 2021-11-29 CN CN202180091901.4A patent/CN116829187A/zh active Pending
- 2021-11-29 CA CA3199351A patent/CA3199351A1/en active Pending
- 2021-11-29 KR KR1020227005324A patent/KR20230114698A/ko active Pending
- 2021-11-29 JP JP2022500682A patent/JPWO2022114165A1/ja not_active Withdrawn
- 2021-11-29 WO PCT/JP2021/043543 patent/WO2022114165A1/ja not_active Ceased
-
2022
- 2022-04-15 JP JP2022067622A patent/JP7802601B2/ja active Active
-
2023
- 2023-05-22 CL CL2023001460A patent/CL2023001460A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018507220A5 (https=) | ||
| JPWO2022114165A5 (https=) | ||
| RU2018146158A (ru) | Антитела | |
| JP2024167313A5 (https=) | ||
| MX2020013068A (es) | Anticuerpo anti proteína reguladora de señales alfa sirpalfana. | |
| JP2020508303A5 (https=) | ||
| JP2010536384A5 (https=) | ||
| JP2008538564A5 (https=) | ||
| IL257281A (en) | Anti-pd-1 antibodies and methods of using them | |
| JP2017113028A5 (https=) | ||
| ME02371B (me) | Sastojci i postupci za dijagnstikovanje i tretman raka | |
| RU2018123717A (ru) | Комбинированные лечения, их применения и способы | |
| RU2011142183A (ru) | Средство для лечения ревматоидного артрита | |
| JP2011504501A5 (https=) | ||
| JP2018521691A5 (https=) | ||
| JP2017528476A5 (https=) | ||
| RU2019100887A (ru) | Композиции антитела и белка | |
| BR112014002613A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica para tratamento e/ou prevenção de câncer, dna e método | |
| RU2010130994A (ru) | Агенты против клетки-мишени, нацеленные на cd138, и их применение | |
| PE20110802A1 (es) | Un anticuerpo antagonista de pcsk9 | |
| CO6231009A2 (es) | Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes | |
| HRP20211444T1 (hr) | Anti-dll3 antitijelo | |
| JP2011518125A5 (https=) | ||
| RU2014150548A (ru) | Терапевтическое средство от зуда | |
| NZ626520A (en) | Anti-lrp5 antibodies and methods of use |